-
Product Insights
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) - Drugs In Development, 2023’, provides an overview of the Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Paraganglioma (Glomus Jugulare Tumor) – Drugs In Development, 2023
Global Markets Direct’s, ‘Paraganglioma (Glomus Jugulare Tumor) - Drugs In Development, 2023’, provides an overview of the Paraganglioma (Glomus Jugulare Tumor) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Paraganglioma (Glomus Jugulare Tumor), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Carcinoid Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Carcinoid Tumor - Drugs In Development, 2023’, provides an overview of the Carcinoid Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Carcinoid Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Neuroendocrine Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroendocrine Cancer - Drugs In Development, 2023’, provides an overview of the Neuroendocrine Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Neuroendocrine Tumors – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroendocrine Tumors - Drugs In Development, 2023’, provides an overview of the Neuroendocrine Tumors pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Tumors, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Neuroendocrine Carcinoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuroendocrine Carcinoma - Drugs In Development, 2023’, provides an overview of the Neuroendocrine Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuroendocrine Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...